Digma Medical
We are about Restoring Glycemic Control! A clinical stage medical device company revolutionizing treatment of Type-2 Diabetes &a; NASH
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Digma Medical Information
Geographic Data
Address:
City: Petah Tiqva
State: HaMerkaz
Zip:
Country: Israel
Financial Info
Stage:
non equity assistance
Raised Last:
$0
Raised Total:$0
Social
Metrics
9,535,962Website Global Rank
141Website Monthly Traffic
Twitter Followers
Description
Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2016 | Series B | 2 | - |
Arkin Holdings Peregrine Ventures Arkin Holdings Peregrine Ventures |
6/2022 | Non Equity Assistance | 1 | - |
MedTech Innovator MedTech Innovator |
4/2015 | Series A | 1 | - |
Accelmed Accelmed |
4/2013 | Seed Round | 2 | - |
Accelmed Office of the Chief Scientist Accelmed Office of the Chief Scientist |
6/2022 | Non Equity Assistance | 1 | - |
MedTech Innovator MedTech Innovator |
12/2016 | Series B | 2 | - |
Arkin Holdings Peregrine Ventures Arkin Holdings Peregrine Ventures |
4/2015 | Series A | 1 | - |
Accelmed Accelmed |
4/2013 | Seed Round | 2 | - |
Accelmed Office of the Chief Scientist Accelmed Office of the Chief Scientist |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
